Nutritional Interventions to Address Deficiencies and Side Effects Associated with the Use of GLP-1 Receptor Agonist: A Systematic Review
Pakistan Journal of Food Sciences · 29.07.2026 · Volume 30 (i2) · 45
DOI: 10.65749/pjfs.2026.30.2.0010 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pakistan Journal of Food Sciences, online erschienen am 29.07.2026. Verfasst von Wareesha Khan und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the management of obesity and type 2 diabetes by promoting weight loss and improving cardiometabolic outcomes. However, gastrointestinal adverse effects and reduced dietary intake may contribute to micronutrient deficiencies, lean body mass loss, poor adherence, and compromised long-term health. This systematic review evaluated nutritional strategies for mitigating these risks in accordance with PRISMA guidelines. PubMed, Scopus, Web of Science, and Google Scholar were searched for studies published between 2010 and 2025. Eligible studies included adults receiving GLP-1 RAs and reporting nutritional deficiencies, gastrointestinal adverse events, dietary intake, lean-mass outcomes, or nutrition interventions. Data were extracted and synthesized thematically. Deficiencies of vitamin D, calcium, magnesium, potassium, iron, and vitamin B12 were frequently reported, together with nausea, vomiting, and delayed gastric emptying. Lean body mass represented approximately 30–40% of total weight loss, emphasizing the importance of adequate protein intake and structured resistance exercise. Individualized micronutrient supplementation, small frequent meals, dietary modification, and comprehensive nutrition counseling helped correct deficiencies, manage symptoms, and improve treatment adherence. Evidence and implementation gaps were particularly apparent for socioeconomically disadvantaged individuals, older adults, and pediatric populations. Although GLP-1 RAs provide substantial metabolic benefits, they may create clinically important nutritional risks. Routine nutritional assessment, symptom monitoring, protein optimization, appropriate supplementation, and exercise support are therefore essential. Future research should establish standardized protocols and evaluate integrated nutrition-care models across diverse real-world populations.
Zitieren
APA
Khan, W., Tahir, A., Akram, A., Siddique, N., Bibi, K., Akhtar, I., Khalid, W., & Khursheed, T. (2026). Nutritional Interventions to Address Deficiencies and Side Effects Associated with the Use of GLP-1 Receptor Agonist: A Systematic Review. Pakistan Journal of Food Sciences, Volume 30(i2), 45. https://doi.org/10.65749/pjfs.2026.30.2.0010
Vancouver
Khan W, Tahir A, Akram A, Siddique N, Bibi K, Akhtar I, et al. Nutritional Interventions to Address Deficiencies and Side Effects Associated with the Use of GLP-1 Receptor Agonist: A Systematic Review. Pakistan Journal of Food Sciences. 2026;Volume 30(i2):45. doi:10.65749/pjfs.2026.30.2.0010
BibTeX
@article{Khan2026,
author = {Khan, Wareesha and Tahir, Areej and Akram, Arooj and Siddique, Nida and Bibi, Kainat and Akhtar, Iqra and Khalid, Warda and Khursheed, Tara},
title = {Nutritional Interventions to Address Deficiencies and Side Effects Associated with the Use of GLP-1 Receptor Agonist: A Systematic Review},
journal = {Pakistan Journal of Food Sciences},
year = {2026},
volume = {Volume 30},
number = {i2},
pages = {45},
doi = {10.65749/pjfs.2026.30.2.0010}
}
EUVIMED